A single dose of Ixchiq induced a high and sustained immune response in 99.1% of adolescents, according to Valneva.

Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted for review GSK 's new drug application (NDA) for Blenrep ...

The Israeli Ministry of Health granted approval for BeiGene’s TEVIMBRA for unresectable or metastatic oesophageal squamous ...

Ossium Health’s PRESERVE I trial is evaluating the safety and effectiveness of its deep-frozen bone marrow from deceased ...

At the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be allowed to advance without political interference.

Catherine Longworth is the Editor for Medical Device Network, covering developments across the medical technology and health ...

Bicara was one of three biotechs that went public last week in one of the busiest biotech IPO windows this year.

The partnership will see AI-enabled screening used to address bioavailability issues with Equillium’s cytokine-targeting ...

The company claims that the FTC’s July 2024 report is riddled with “false and misleading claims” about the PBM industry.

Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating atopic dermatitis in adults and children over 12 ...

The clinical hold was placed on three studies investigating azenosertib in June after two patients died due to presumed ...

The FDA’s RMAT designation for P-BCMA-ALLO1 applies to adult patients with relapsed/refractory multiple myeloma who have ...